ALLMedicine™ Lung Transplantation Center

May 10th, 2022 - Multiple biomarkers have been investigated in the risk stratification of patients with pulmonary arterial hypertension (PAH). This systematic review and meta-analysis is the first to investigate the prognostic value of (NT-pro)BNP in patients with...

May 9th, 2022 - Commentary: Challenging the final frontier of lung transplantation.|2022|Thomas PA,|

May 9th, 2022 - Organ procurement is intimately tied to the history of organ transplantation and organ donation. To best understand the organ procurement process, reviewing the history of transplantation is helpful. Notable events have included the following: 190...

May 9th, 2022 - Overview Organ procurement is intimately tied to the history of organ transplantation and organ donation. To best understand the organ procurement process, reviewing the history of transplantation is helpful. Notable events have included the follo...

May 7th, 2022 - Bronchiolitis obliterans syndrome (BOS) is a major cause of morbidity and mortality in lung transplantation and allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Clinical guidelines recommend lung function monitoring to ai...

Apr 5th, 2022 - Controlled organ donation after circulatory determination of death is increasingly being used for the donation of organs also in thoracic transplantation. This document outlines the position of the International Society for Heart and Lung Transpla...

Nov 5th, 2021 - International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document.|2021|Marczin N,de Waal EEC,Hopkins PMA,Mulligan MS,Simon A,|

Sep 7th, 2021 - In selected SARS-CoV-2–infected nonlung donors, risk for donor-to-recipient transmission appears very low. In all deceased potential organ donors, upper respiratory tract specimens are tested for SARS-CoV-2. If lung transplantation is being con...

Sep 4th, 2021 - Patients with connective tissues disease (CTD) are often on immunomodulatory agents before lung transplantation (LTx). Till now, there's no consensus on the safety of using these agents perioperative and post-transplant. The International Society ...

Aug 23rd, 2021 - Tens of thousands of patients with advanced lung diseases may be eligible to be considered as potential candidates for lung transplant around the world each year. The timing of referral, evaluation, determination of candidacy, and listing of candi...

May 4th, 2022 - This is a pilot study to determine the feasibility and utility of Novel Functional Lung Imaging and Ventilation (4DxV) Analysis software in measurement of lung ventilation abnormalities and diagnosis of CLAD after lung transplantation. 4DxV is a t...

May 3rd, 2022 - Introduction: Lung transplantation (TxP) is now a validated treatment of end-stage pulmonary diseases, but long-term graft and patient survival are still hampered by the development of chronic allograft dysfunction (CLAD) affecting > 50% of patien...

May 2nd, 2022 - Despite advances in lung transplantation, median survival remains only 55% at 5 years. The primary cause of death is chronic lung allograft dysfunction (CLAD), occurring in 43% of recipients at 5 years. Recently, it has been recognized that CLAD c...

Apr 26th, 2022 - The primary aim of this study is to establish the safety of infusions of Mesenchymal Stromal Cells (MSC) from related or unrelated Human Leukocyte Antigen (HLA) identical or HLA mismatched donors in the management of bronchiolitis obliterans syndr...

Mar 16th, 2022 - Pulmonary Disorders, including both COPD & Restrictive Lung Disease (RLD) are often treated by limiting exposure to poor air quality, but there is no cure at this time. Most commonly, the patients are treated upon exacerbations, usually with some ...

Apr 19th, 2022 - Poor cough-specific quality of life (QOL) was independently associated with respiratory hospitalization, death, and lung transplantation in a large population of well-characterized patients with interstitial lung disease (ILD), new research shows....

Mar 25th, 2022 - Surgeons at Northwestern Medicine in Chicago have successfully performed a double lung transplant on a patient with stage 4 lung cancer, the health system reports. Lung transplantation for lung cancer is rare, and this double lung transplant — the...

Mar 10th, 2022 - David Mason, MD Amid the ongoing explosion of immunotherapy and targeted agents in non—small cell lung cancer (NSCLC), surgery remains a key component of the armamentarium. Surgery may be less of an option for patients with metastatic disease, b...

Mar 10th, 2022 - David P. Mason, MD, chief of thoracic surgery and lung transplantation, Baylor Scott & White Health System, chief of lung transplantation, head of the Department of Thoracic Surgery, Baylor University Medical Center, discusses the progress that ha...

Mar 10th, 2022 - David P. Mason, MD, chief, Thoracic Surgery and Lung Transplantation, Baylor Scott & White Center for Thoracic Surgery, discusses the reliability of the PD-L1 biomarker in non—small cell lung cancer (NSCLC) and its potential applications in surgic...